BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 15800758)

  • 21. Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna.
    Keles I; Bozkurt MF; Cemek M; Karalar M; Hazini A; Alpdagtas S; Keles H; Yildiz T; Ceylan C; Buyukokuroglu ME
    Int Urol Nephrol; 2014 Dec; 46(12):2301-10. PubMed ID: 25248628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain.
    Boucher M; Meen M; Codron JP; Coudore F; Kemeny JL; Eschalier A
    J Urol; 2000 Jul; 164(1):203-8. PubMed ID: 10840460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats.
    Korkmaz A; Oter S; Sadir S; Coskun O; Topal T; Ozler M; Bilgic H
    J Urol; 2005 May; 173(5):1793-6. PubMed ID: 15821589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis - comparison of the effects of dexamethasone and Mesna.
    Morais MM; Belarmino-Filho JN; Brito GA; Ribeiro RA
    Braz J Med Biol Res; 1999 Oct; 32(10):1211-5. PubMed ID: 10510257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic effect of cyclophosphamide on sperm morphology, testicular histology and blood oxidant-antioxidant balance, and protective roles of lycopene and ellagic acid.
    Ceribaşi AO; Türk G; Sönmez M; Sakin F; Ateşşahin A
    Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):730-6. PubMed ID: 20353483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats.
    Sinanoglu O; Yener AN; Ekici S; Midi A; Aksungar FB
    Urology; 2012 Dec; 80(6):1392.e1-6. PubMed ID: 22951000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
    Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
    Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytoprotective effects of DL-alpha-lipoic acid or squalene on cyclophosphamide-induced oxidative injury: an experimental study on rat myocardium, testicles and urinary bladder.
    Motawi TM; Sadik NA; Refaat A
    Food Chem Toxicol; 2010; 48(8-9):2326-36. PubMed ID: 20573578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprotective effect of lipoic acid against cyclophosphamide-induced changes in the rat sperm.
    Selvakumar E; Prahalathan C; Sudharsan PT; Varalakshmi P
    Toxicology; 2006 Jan; 217(1):71-8. PubMed ID: 16207511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The uroprotection of mesna on cyclophosphamide cystitis in rats. Its consequences on behaviour and brain activities.
    Menétrey D; Bon K; Michiels JF; Lantéri-Minet M
    C R Acad Sci III; 1999 Jun; 322(6):505-15. PubMed ID: 10457601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of poly(ADP-ribose) polymerase inhibition in bladder damage caused by cyclophosphamide in rats.
    Korkmaz A; Kurt B; Yildirim I; Basal S; Topal T; Sadir S; Oter S
    Exp Biol Med (Maywood); 2008 Mar; 233(3):338-43. PubMed ID: 18296739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation.
    Korkmaz A; Topal T; Oter S
    Cell Biol Toxicol; 2007 Sep; 23(5):303-12. PubMed ID: 17225077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of uroprotective efficacy of amifostine against cyclophosphamide induced hemorrhagic cystitis.
    Srivastava A; Nair SC; Srivastava VM; Balamurugan AN; Jeyaseelan L; Chandy M; Gunasekaran S
    Bone Marrow Transplant; 1999 Mar; 23(5):463-7. PubMed ID: 10100560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
    Freedman A; Ehrlich RM; Ljung BM
    J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seleno L-methionine acts on cyclophosphamide-induced kidney toxicity.
    Ayhanci A; Günes S; Sahinturk V; Appak S; Uyar R; Cengiz M; Altuner Y; Yaman S
    Biol Trace Elem Res; 2010 Aug; 136(2):171-9. PubMed ID: 19826776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoguanidine, selective nitric oxide synthase inhibitor, ameliorates cyclophosphamide-induced hemorrhagic cystitis by inhibiting protein nitration and PARS activation.
    Abraham P; Rabi S; Kulothungan P
    Urology; 2009 Jun; 73(6):1402-6. PubMed ID: 19251306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.
    Scheef W; Klein HO; Brock N; Burkert H; Günther U; Hoefer-Janker H; Mitrenga D; Schnitker J; Voigtmann R
    Cancer Treat Rep; 1979 Mar; 63(3):501-5. PubMed ID: 106965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vitamin C and N-acetylcysteine against cyclophosphamide-induced genotoxicity in exfoliated bladder cells of mice in vivo.
    Gurbuz N; Ozkul A; Burgaz S
    J BUON; 2009; 14(4):647-52. PubMed ID: 20148457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.